| Financial Year |
March 31 2023 |
| Monetary Funds |
223,396,767.93 |
| Held-for-trading Financial Assets |
110,600.49 |
| Notes Receivable |
42,767,661.83 |
| Accounts Receivable |
333,449,743.16 |
| Advances to Suppliers |
44,257,241.15 |
| Other Receivables |
4,355,764.60 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
358,338,916.16 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
7,595,554.52 |
| Total Current Assets |
1,218,304,595.18 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
67,567,374.50 |
| Investment Properties |
-- |
| Fixed Assetes |
1,486,626,640.96 |
| Under-construction Projects |
250,816,752.94 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
121,347,933.66 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
28,106,441.08 |
| Other Non-Current Assets |
203,588,491.99 |
| Sub-Total of Non-Current Assets |
2,158,053,635.13 |
| Total Assets |
3,376,358,230.31 |
| Short-Term Loans |
458,441,356.79 |
| Trading Financial liabilities |
-- |
| Notes Payable |
188,803,758.20 |
| Accounts Payable |
146,113,228.16 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
18,710,828.35 |
| Taxes Payable |
10,467,913.52 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
1,058,149.43 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
282,216.82 |
| Sub-Total of Current Liabilities |
826,048,349.92 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
23,367,418.92 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
139,516,293.17 |
| Total Liabilities |
965,564,643.09 |
| Paid-In Capital(Or Share Stock) |
646,208,651.00 |
| Capital Surplus |
1,268,786,568.57 |
| Surplus Reserve |
141,273,484.70 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
354,524,882.95 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,410,793,587.22 |
| Owner's Equity（Stockholder's Equity） |
2,410,793,587.22 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,376,358,230.31 |
